Amgen Inc
AMGN
AMGN: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).
moreShow AMGN Financials
$AMGN is featured in our Shelley Moore Capito strategy.
See All StrategiesAll
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of AMGN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AMGN's directors and management
Government lobbying spending instances
-
$1,950,000 Jul 21, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2023 Issue: Health Issues
-
$60,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Jul 19, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$50,000 Jul 19, 2023 Issue: Health Issues
-
$60,000 Jul 18, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
-
$60,000 Jul 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
-
$2,800,000 Apr 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$60,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
-
$50,000 Apr 20, 2023 Issue: Health Issues
-
$60,000 Apr 19, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Apr 19, 2023 Issue: Health Issues
-
$60,000 Apr 19, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
-
$50,000 Apr 17, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Jan 20, 2023 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$2,140,000 Jan 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$80,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$50,000 Jan 19, 2023 Issue: Health Issues
-
$80,000 Jan 14, 2023 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$80,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2022 Issue: Health Issues
-
$50,000 Oct 19, 2022 Issue: Health Issues
-
$3,150,000 Oct 18, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$80,000 Oct 16, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$60,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$2,200,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,410,000 Jul 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2022 Issue: Health Issues
-
$80,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Jul 19, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Jul 19, 2022 Issue: Health Issues
-
$80,000 Jul 15, 2022 Issue: Communications/Broadcasting/Radio/TV Health Issues Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$2,780,000 Apr 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$50,000 Apr 20, 2022 Issue: Health Issues
-
$80,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Health Issues
-
$80,000 Apr 15, 2022 Issue: Health Issues Medicare/Medicaid
-
$70,000 Jan 21, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$2,410,000 Jan 20, 2022 Issue: None
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$80,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2022 Issue: Health Issues
-
$80,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$80,000 Jan 15, 2022 Issue: None
-
$70,000 Oct 20, 2021 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$2,620,000 Oct 20, 2021 Issue: None
-
$80,000 Oct 20, 2021 Issue: Copyright/Patent/Trademark Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 18, 2021 Issue: Health Issues
-
$80,000 Oct 18, 2021 Issue: None
-
$80,000 Oct 15, 2021 Issue: Health Issues Medicare/Medicaid
-
$80,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$70,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$1,910,000 Jul 20, 2021 Issue: None
-
$50,000 Jul 20, 2021 Issue: Health Issues
-
$80,000 Jul 19, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$50,000 Jul 19, 2021 Issue: Health Issues
-
$80,000 Jul 17, 2021 Issue: None
-
$2,810,000 Apr 20, 2021 Issue: None
-
$80,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$80,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2021 Issue: Health Issues
-
$50,000 Apr 19, 2021 Issue: Health Issues
-
$80,000 Apr 18, 2021 Issue: Medicare/Medicaid Health Issues
-
$80,000 Apr 17, 2021 Issue: MEDICARE/MEDICAID
-
$60,000 Jan 21, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 21, 2021 Issue: Health Issues
-
$80,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2021 Issue: Health Issues
-
$2,560,000 Jan 20, 2021 Issue: None
-
$80,000 Jan 19, 2021 Issue: Health Issues Medicare/Medicaid
-
$80,000 Jan 19, 2021 Issue: MEDICARE/MEDICAID
-
$60,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$2,920,000 Oct 20, 2020 Issue: None
-
$80,000 Oct 20, 2020 Issue: MEDICARE/MEDICAID
-
$50,000 Oct 20, 2020 Issue: Health Issues
-
$50,000 Oct 20, 2020 Issue: Health Issues
-
$80,000 Oct 19, 2020 Issue: Health Issues Medicare/Medicaid
-
$80,000 Oct 19, 2020 Issue: Health Issues Medicare/Medicaid
-
$2,970,000 Jul 20, 2020 Issue: None
-
$80,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$80,000 Jul 20, 2020 Issue: MEDICARE/MEDICAID
-
$60,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Health Issues
-
$50,000 Jul 18, 2020 Issue: Health Issues
-
$80,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
-
$2,700,000 Apr 20, 2020 Issue: None
-
$50,000 Apr 20, 2020 Issue: Health Issues
-
$80,000 Apr 20, 2020 Issue: MEDICARE/MEDICAID
-
$60,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$80,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$50,000 Apr 19, 2020 Issue: Health Issues
-
$80,000 Apr 17, 2020 Issue: Health Issues Medicare/Medicaid
-
$2,400,000 Jan 21, 2020 Issue: None
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on AMGN's company Twitter account
WallStreetBets
Number of mentions of AMGN in WallStreetBets Daily Discussion
AMGN News
Recent insights relating to AMGN
CNBC Recommendations
Recent picks made for AMGN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in AMGN
Corporate Flights
Flights by private jets registered to AMGN